Top 10 Logistics Stocks For 2014

The U.S. Department of Defense awarded Raytheon (NYSE: RTN  ) a pair of contracts Wednesday -- one big, one small.

The big one -- in fact, the biggest contract the Pentagon awarded to anyone Wednesday -- is worth $83.8 million to Raytheon. A sole-source, cost-plus-incentive-fee, and cost-plus-fixed-fee foreign military sales contract modification, it hires Raytheon to perform software updates, radar repairs, logistics, and other work on AN/TPY-2 radars being provided to the government of the United Arab Emirates for use as part of Lockheed Martin's (NYSE: LMT  ) new Terminal High Altitude Area Defense, or THAAD, system.�

�Lockheed Martin won the $2 billion contract to build a THAAD system for the UAE in 2011. Raytheon will be working on this contract through Sept. 30, 2018.�

The smaller award, worth $19.1 million to Raytheon, hires the company to provide engineering and technical services to the U.S. Navy, other U.S. government agencies, and also foreign governments -- all related to Raytheon's Standard Missiles, models 2, 3, and 6. Foreign governments for which Raytheon will be doing work under this contract include Japan, Australia, South Korea, Germany, the Netherlands, Taiwan, Canada, and Spain. Work on this contract should be completed by next July.

Hot Cheapest Stocks For 2015: Rolls-Royce Holdings PLC (RYCEY)

Rolls-Royce Holdings plc, formerly Rolls-Royce Group plc is a provider of power systems and services for use on land, at sea and in the air. The Company operates in four segments: civil aerospace, defense aerospace, marine and energy. The civil aerospace is engaged in development, manufacture, marketing and sales of commercial aero engines and aftermarket services. The defense aerospace is engaged in development, manufacture, marketing and sales of military aero engines and aftermarket services. The marine segment is engaged in development, manufacture, marketing and sales of marine propulsion systems and aftermarket services. The energy segment is engaged in development, manufacture, marketing and sales of power systems for the offshore oil and gas industry and electrical power generation and aftermarket services. In January 2013, the Company bought PKMJ Technical Services. In January 2013, Alstom SA acquired Tidal Generation Limited from the Company.

During the year ended December 31, 2010, it acquired ODIM ASA. In June 2011, Daimler AG and Rolls-Royce Holdings PLC had secured around 94% interest in Tognum AG-DJ. In September 2011, the Company acquired R Brooks Associates.

Civil aerospace

The Company�� civil aerospace business provides the powers for 30 different types of commercial aircraft in a range of markets, such as widebody, narrowbody, corporate and regional aircraft. As of December 31, 2010, it had over 13,000 engines in service with 650 airlines, freight operators and lessors and 4,000 corporate operators. Its civil aerospace products include large aircraft engines, small aircraft engines and helicopter engines. The Company�� Trent 700 is an engine on the Airbus A330. The Trent 1000 is powering the Boeing 787 on the aircraft�� flight test schedule. It provides a range of services, such as TotalCare, CorporateCare, helicopters services, financial services, training and technical publications.

Defence Aerospace

The Compan! y is a provider of defence aero-engine products and services, with 18,000 engines in service for 160 customers in 103 countries. It is also the supplier of engines for transport aircraft globally, powering fleets, such as the C-130, C-130J, Spartan C-27 and Osprey V-22. It is also involved in research projects, such as Adoptive Versatile Engine Technology (ADVENT), which is designed to reduce fuel consumption. Its engines power aircraft in all sectors, such as transport, combat, reconnaissance, training, helicopters and unmanned aerial vehicles. The defense aerospace segment of the Company provides engines power aircraft in all sectors, such as transport, combat, reconnaissance, training, helicopters and unmanned aerial vehicles. Its products include combat jets, helicopters, transporters, trainers, tactical aircraft, unmanned aerial vehicles and distributed generation systems. It provides a range of services, such as training, technical publications and service locations.

Marine

The Company focuses on power, propulsion and motion control solutions and serves over 2,500 customers and has equipment installed on 30,000 vessels operating worldwide. As of December 31, 2010, the Company had 650 designed and equipped vessels operating in the offshore oil and gas sector. As of December 31, 2010, it had more than 2,500 marine customers and has equipment installed on over 30,000 vessels worldwide, including those of 70 navies. The energy business supplies gas turbines, compressors and diesel power units. Its products include automation and control, bearings and seals, deck machinery, electrical power systems, engines, gears, propulsors, ship design, shiplifts and submarine equipment. It provides a range of services, such as global support network, spares and tools, field shop services, technical support, training, tailored solutions and upgrading.

Energy

The Company is a provider of gas turbines for onshore and offshore applications. The Company�� energy busi! ness is e! ngaged in two activities: supply power to the oil and gas sector, and the provision of power generation products and services. Its products include gas engines, gas turbine engines, gas compression, diesel engines, fuel cells, and automation and control systems. Its services consist of long term service agreements, component supply and technical support, distributed generation systems and training. During the year ended December 31, 2010, it conducted a range of a tidal power turbine, anchored on the sea bed off the coast of Scotland. During 2010, this had generated 500 kilo-watt at full power and has been successfully linked into the national grid.

Advisors' Opinion:

• [By Alan Oscroft]

  Rolls-Royce (LSE: RR  ) (NASDAQOTH: RYCEY  )
  Having reached 1,148 pence this morning to set a new 52-week high, Rolls-Royce Holdings shares are now up 40% since this time last year. That was partly due to a strong 2012, which saw a 22% rise in earnings per share and an 11% rise in the dividend -- albeit with a modest yield of 2.2% on the year-end price.

• [By CanadianValue]

  At Rolls-Royce (RYCEY), new CEO John Rishton had a busy and fruitful start to his tenure. Most importantly, Rishton began to focus Rolls on areas where the company stood to improve, including cash generation, cost structure and customer service. He also successfully extracted the company from its legacy narrow body civil engine joint-venture with Pratt & Whitney (IAE) for an attractive price, positioned Rolls as exclusive supplier for the Airbus A350-1000, further secured the company�� strong position on the A350 program, and closed the tricky Tognum acquisition which will begin to bear fruit in 2012. While Rolls had not released its 2011 results as of the writing of this letter, both we and the markets expect the company to report mid-to-high single digits revenue growth and low-to-mid-teens earnings growth in the year past.

• [By Rich Smith]

  The Department of Defense awarded a round dozen defense contracts Friday, worth just under $7.2 billion in aggregate. The bulk of the contracts -- $7 billion worth -- were split among eight small privately held firms scattered around New Jersey, Maryland, Indiana, and Virginia contracted to supply software and systems engineering services in support of the Army's Software Engineering Center. But a handful of better-known -- and, more importantly to investors, publicly traded -- companies won contracts as well. Namely:

Top 10 Logistics Stocks For 2014: ParkerVision Inc.(PRKR)

Parkervision, Inc. engages in the design, development, and sale of proprietary radio frequency (RF) technologies and products for use in semiconductor circuits for wireless communication products in the United States. The company provides its wireless technologies for processing RF waveforms in wireless applications. Its technology applies to transmit and receive functions of a radio transceiver. Its transmit portion of the technology, Direct2Power, enables the transformation of a baseband data signal to an RF carrier waveform at the desired power output level in a single unified operation. The company?s receiver portion of the technology, Direct2Data, enables the direct conversion of an RF carrier to a baseband data signal. It also provides engineering consulting and design services to its customers to assist them in developing prototypes and/or products incorporating its technologies. The company licenses its intellectual property and sells integrated circuits for incor poration into wireless devices designed by its customers. It primarily focuses on incorporating its technologies into mobile handsets, as well as to other wireless products that are related to networks serving mobile handsets, such as data cards, femtocells, and machine-to-machine and embedded applications. The company?s technology is also used in non-cellular radio applications comprising military radios. In addition, Parkervision, Inc. develops wireless radio modules for mobile handset and data card applications through a joint development and marketing agreement with LG Innotek Co., Ltd. It serves mobile handset manufacturers and their chipset suppliers in the mobile handset industry. The company was founded in 1989 and is headquartered in Jacksonville, Florida.

Advisors' Opinion:

• [By Bryan Murphy]

  I don't come hear to pat myself on the back, however. I come hear to let you know the same conditions that made American Community overbought and ripe for a reversal and suggested Real Goods Solar, Inc. was ready to rally are now saying - respectively - ParkerVision, Inc. (NASDAQ:PRKR) shares are due for a pullback and Arca Biopharma Inc. (NASDAQ:ABIO) is on the verge of a big bullish thrust.

• [By Paul Ausick]

  Stocks on the Move: ParkerVision Inc. (NASDAQ: PRKR) is down 59.2% at $2.89 following a smaller-than-hoped-for award in its patent suit against Qualcomm Inc. (NASDAQ: QCOM). NQ Mobile Inc. (NYSE: NQ) is down 50.7% at $11.28 following a blistering from analysts at Muddy Waters.

• [By Paul Ausick]

  Stocks on the Move: Voxeljet AG (NYSE: VJET) is up 121.8% at $28.83 after a blazing hot IPO. Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is down 40.7% at $2.67 on a failed drug trial. ParkerVision Inc. (NASDAQ: PRKR) is up 17.9% at $6.40 after gaining more than 60% yesterday on a Florida jury�� ruling in the company�� favor in a patent suit against Qualcomm Inc. (NASDAQ: QCOM). J.C. Penney Co. Inc. (NYSE: JCP) is down 4.8% at $7.00, after posting a 33-year low of $6.97 a share earlier today.

Top 10 Logistics Stocks For 2014: Entertainment Properties Trust (EPR)

EPR Properties, a real estate investment trust (REIT), develops, owns, leases, and finances entertainment and related properties in the United States and Canada. Its properties include megaplex theatres, entertainment retail centers, and destination recreational and specialty properties. As of December 31, 2007, the company had a real estate portfolio of 79 megaplex theatre properties located in 26 states in the U.S. and Ontario, Canada; 1 additional theatre property under development; 8 entertainment retail centers located in Westminster, Colorado, New Rochelle, New York, White Plains, New York, Burbank, California, and Ontario, Canada; and 1 additional entertainment retail center under development and land parcels leased to restaurant and retail operators. EPR Properties qualifies as a REIT under the Internal Revenue Code and would not be subject to federal income tax to the extent that it distributes at least 90% of its taxable income to its shareholders. The company wa s founded in 1997 and is based in Kansas City, Missouri.

Advisors' Opinion:

• [By Lawrence Meyers]

  I also jumped on the 9% Preferred Series E of an interesting REIT called EPR Properties (EPR), a $2.38 billion trust that owns 114 megaplex movie theaters; nine entertainment retail centers; seven family entertainment centers where one can bowl, enjoy nightlife, or sit atop observational towers; 13 metro ski parks; three water parks; four golf complexes, and 48 public charter schools.

• [By Monica Gerson]

  EPR Properties (NYSE: EPR) closed a deal to acquire the Camelback Mountain Resort in Tannersville, PA, for around $70 million. EPR Properties shares gained 0.31% to close at $48.59 on Friday.

• [By Marc Bastow]

  Entertainment properties real estate investment trust EPR Properties (EPR) raised its monthly dividend 28.5 cents per share, payable Feb. 18 to shareholders of record Jan. 31. EPR stock is the highest yielder of this week’s dividend stocks.
  EPR Dividend Yield: 6.77%

Top 10 Logistics Stocks For 2014: Methanex Corporation (MEOH)

Methanex Corporation, together with its subsidiaries, engages in the production, marketing, and sale of methanol. The company also purchases and re-sells methanol produced by others. Its methanol is a clear liquid commodity chemical that is used to produce traditional chemical derivatives, including formaldehyde, acetic acid, and various other chemicals. The company�s methanol is also used in energy-related applications; for blending into gasoline, as a feedstock in the production of dimethyl ether, which can be blended with liquefied petroleum gas for use in household cooking and heating, and in the production of biodiesel; and used to produce methyl tertiary-butyl ether, a gasoline component, as well as used into olefins applications. The company supplies its methanol to petrochemical producers and distributors in North America, the Asia Pacific, Europe, and Latin America. Methanex Corporation was founded in 1968 and is headquartered in Vancouver, Canada.

Advisors' Opinion:

• [By Mani]

  [Related -Methanex (MEOH) Downgraded To 'Sector Underperformer' By CIBC, PT Raised]

  From a long-term perspective, a modest near-term softening in methanol prices is a net positive as elevated levels have left the market increasingly concerned over the potential impact on future energy derivative demand growth and the potential for elevated prices to continue to incentivize new capacity announcements.

Top 10 Logistics Stocks For 2014: India Fund Inc (IFN)

The India Fund, Inc. (the Fund), incorporated on December 27, 1993, is a non-diversified, closed-end management investment company. The Fund�� investment objective is long-term capital appreciation. It invests in Indian equity securities. At least 80% of the Fund�� total assets are invested in equity securities of Indian companies. Its portfolio includes common stocks, warrants and short-term investments. The India Fund, Inc. operates through a branch in the Republic of Mauritius.

The India Fund, Inc. invests in a range of industries, including computer software and programming, computer services, finance, diversified industries, building and construction, cement, chemicals, electronics and electrical equipment, extractive industries, engineering, diversified financial services, petroleum-related industries, pharmaceuticals, steel and telecommunications. Aberdeen Asset Management Asia Limited is the Fund�� investment manager.

Advisors' Opinion:

• [By Jon C. Ogg]

  The India Fund Inc. (NYSE: IFN) is a closed-end fund that trades often at severe discounts or premiums to the net asset value. Its gain is only 0.9% to $18.03, and the 52-week trading range of $16.88 to $24.10 implies that it has recovered only 7% off of its recent lows. It currently trades at a discount of 11% to its NAV according to CEFA.com.

• [By Jon C. Ogg]

  The India Fund Inc. (NYSE: IFN) is down another 5% at $17.55 against a 52-week range of $17.53 to $24.10. CEFA.com shows that it trades at roughly a 9.4% discount to its net asset value.

• [By Jon C. Ogg]

  WisdomTree�India Earnings Fund (NYSEMKT: EPI) is down yet another 2.7% at $13.05, and it hit a new low of $13.00 on Wednesday against a high of $20.50. The PowerShares India (NYSEMKT: PIN) is down another 2.5% at $13.54, and it hit a new low with its 52-week range now at $13.50 to $19.66. The India Fund Inc. (NYSE: IFN) is a closed-end fund rather than an exchange traded fund (ETF), and it is down almost 1.75% at $16.95, with its shares hitting a new multiyear low of 416.88, against a 52-week high of $24.10.

Top 10 Logistics Stocks For 2014: Synovus Financial Corp.(SNV)

Synovus Financial Corp., a diversified financial services and bank holding company, provides commercial and retail banking, financial management, insurance, and mortgage services in Georgia, Alabama, South Carolina, Florida, and Tennessee. Its retail banking services include accepting customary types of demand and savings deposits; mortgage, installment, and other retail loans; investment and brokerage services; safe deposit services; automated banking services; automated fund transfers; Internet based banking services; and bank credit card services, including mastercard and visa services. The company?s commercial banking services comprise cash management and asset management services, capital markets services, and institutional trust services, as well as commercial, financial, and real estate loans. It also provides various other financial services, which include the portfolio management for fixed-income securities, investment banking, the execution of securities transac tions as a broker/dealer, and the provision of individual investment advice on equity and other securities; trust services; mortgage services; and financial planning services. Synovus Financial Corp. was founded in 1888 and is headquartered in Columbus, Georgia.

Advisors' Opinion:

• [By Selena Maranjian]

  Caxton Associates reduced its stake in lots of companies, including Georgia-based Synovus Financial (NYSE: SNV  ) . Synovus has been posting strong return-on-equity (ROE) numbers. In May, it acquired $54 million in deposits from the failed Sunrise Bank. Bears worry about the bank's significant residential real estate business and the current low interest rate environment. It has also been working to pay off its TARP obligations.

• [By Rich Duprey]

  Southeastern regional bank�Synovus Financial (NYSE: SNV  ) �announced this morning�its second-quarter dividend of $0.01 per share, the same rate it's paid since 2009.

• [By Eric Volkman]

  Synovus (NYSE: SNV  ) is tapping the markets for a fresh round of financing. The company announced that it will float just under 59.9 million shares of its common stock in an underwritten public offering priced at $3.09 per share. The estimated net proceeds of the issue are estimated at $175 million. This cash pile, in conjunction with a planned preferred stock issue and dividends from a subsidiary, will be used to repay nearly $1 billion in TARP funds the government provided to Synovus.

Top 10 Logistics Stocks For 2014: Orexigen Therapeutics Inc.(OREX)

Orexigen Therapeutics, Inc., a development stage company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed phase III clinical trials; and Empatic that has completed phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; and naltrexone is a treatment for alcohol and opioid addiction. The company?s Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide is for the adjunctive treatment of partial seizures, a form of epilepsy. The company has a collaboration agreement with Takeda Pharmaceutical Company Limited to develop and commercialize Contrave. Orexigen Therapeutics, Inc. was founded in 2002 and is based in La Jolla, California.

Advisors' Opinion:

• [By Stephen Simpson, CFA]

  That may be a hard deal model for Lexicon to get, though, given that its drug will be arriving late to the SGLT party. The company may have to instead settle for an arrangement more like the ones Arena (ARNA) and Orexigen (OREX) negotiated for their obesity drugs where there was less money upfront, but a more generous split on the back end.

• [By Brian Orelli]

  After getting rejected once, Arena Pharmaceuticals' (NASDAQ: ARNA  ) Belviq and VIVUS'� (NASDAQ: VVUS  ) Qsymia were both approved by the FDA last year. And the FDA seems open to approving a third drug, Orexigen's (NASDAQ: OREX  ) Contrave.

• [By John Udovich]

  Orexigen Therapeutics, Inc (NASDAQ: OREX), like Arena Pharmaceuticals, Inc (NASDAQ: ARNA), EnteroMedics Inc (NASDAQ: ETRM) and VIVUS, Inc (NASDAQ: VVUS), is a speculative small cap obesity drug stock that has the potential for coming up with the next big thing in the treatment of obesity that is increasingly a global problems. I should mention that we have recently added Orexigen Therapeutics to our SmallCap Network Elite Opportunity (SCN EO) portfolio as an extremely speculative biotech bet because its�lead obesity drug candidate has the potential to be�approved by September 11th of this year.

• [By John Udovich]

  Small cap biotech Arena Pharmaceuticals, Inc (NASDAQ: ARNA) soared yesterday and last Friday on earnings as well as news that the company will expand its marketing and supply agreement with Japan based Eisai for its BELVIQ (lorcaserin HCl) obesity drug, meaning it might be time to take a closer look at other biotech stocks like Orexigen Therapeutics, Inc (NASDAQ: OREX), EnteroMedics Inc (NASDAQ: ETRM) and VIVUS, Inc (NASDAQ: VVUS) that are in the business of treating obesity. Specifically, Arena Pharmaceuticals announced an expanded agreement providing Eisai with exclusive commercialization rights for all countries worldwide (except for South Korea, Taiwan, Australia, Israel and New Zealand) for BELVIQ where Arena will receive an upfront payment of $60 million and is eligible to receive up to a total of $176.5 million in regulatory and development milestone payments - an increase of $123 million from the amount remaining available under the previous agreement. BELVIQ was approved in June 2012, but didn't reach the market until June 2013 due to logistical concerns like classification by the Drug Enforcement Administration. Its also�approved for use in adults who are obese or who are overweight and who have at least one serious medical condition (e.g. diabetes or high cholesterol).